Integra LifeSciences Updates 2017 Guidance; Q4 Profit Matches Estimate

(RTTNews) - Integra LifeSciences Holdings Corp. (IART) announced the company expects full year 2017 revenues to be between $1.12 billion and $1.14 billion, including the Derma Sciences acquisition, and organic sales growth to be between 7% and 8.5%. The company expects GAAP EPS for the full year to be between $0.49 and $0.55, and adjusted EPS to be between $1.88 and $1.94.

Fourth-quarter GAAP earnings per share amounted to $0.35, a 75% increase over the prior year period; adjusted EPS amounted to $0.52, or an increase of 18%. On average, 15 analysts polled by Thomson Reuters expected the company to report profit per share of $0.52, for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter revenue increased 6.0% over the prior-year quarter to $255.7 million, with organic revenues up 7.0%. Analysts expected revenue of $257.27 million, for the quarter.